MANN MICHAEL SCOTT (President) purchased 0.0% of their position (8K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $338.90 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+1K
Price / share
$0.04
Trade value
$43.00
% of position
Common Stock
Shares
+1K
Price / share
$0.04
Trade value
$42.40
% of position
Common Stock
Shares
+1K
Price / share
$0.04
Trade value
$41.50
% of position
Common Stock
Shares
+1K
Price / share
$0.04
Trade value
$42.40
% of position
Common Stock
Shares
+1K
Price / share
$0.04
Trade value
$42.40
% of position
Common Stock
Shares
+1K
Price / share
$0.04
Trade value
$42.20
% of position
Common Stock
Shares
+2K
Price / share
$0.04
Trade value
$85.00
% of position
Net shares
+8K
Net value
$338.90
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/23/2018 | P · Purchase | +1K | $0.04 | $43.00 | 0.0% | 26.08M | 26.08M |
| Common Stock Direct | 10/23/2018 | P · Purchase | +1K | $0.04 | $42.40 | 0.0% | 26.08M | 26.08M |
| Common Stock Direct | 10/23/2018 | P · Purchase | +1K | $0.04 | $41.50 | 0.0% | 26.08M | 26.09M |
| Common Stock Direct | 10/23/2018 | P · Purchase | +1K | $0.04 | $42.40 | 0.0% | 26.09M | 26.09M |
| Common Stock Direct | 10/23/2018 | P · Purchase | +1K | $0.04 | $42.40 | 0.0% | 26.09M | 26.09M |
| Common Stock Direct | 10/24/2018 | P · Purchase | +1K | $0.04 | $42.20 | 0.0% | 26.09M | 26.09M |
| Common Stock Direct | 10/26/2018 | P · Purchase | +2K | $0.04 | $85.00 | 0.0% | 26.09M | 26.09M |
| Total | +8K | $338.90 | ||||||